Cytek Biosciences, Inc. (CTKB)
4.71
+0.09
(+1.95%)
USD |
NASDAQ |
Sep 09, 14:53
Cytek Biosciences Total Assets (Quarterly) : 446.93M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 446.93M |
| March 31, 2026 | 449.11M |
| December 31, 2025 | 461.54M |
| September 30, 2025 | 494.92M |
| June 30, 2025 | 493.32M |
| March 31, 2025 | 482.60M |
| December 31, 2024 | 502.08M |
| September 30, 2024 | 491.23M |
| June 30, 2024 | 483.72M |
| March 31, 2024 | 492.07M |
| December 31, 2023 | 497.67M |
| September 30, 2023 | 519.43M |
| Date | Value |
|---|---|
| June 30, 2023 | 525.05M |
| March 31, 2023 | 524.58M |
| December 31, 2022 | 523.52M |
| September 30, 2022 | 499.30M |
| June 30, 2022 | 492.82M |
| March 31, 2022 | 485.88M |
| December 31, 2021 | 464.08M |
| September 30, 2021 | 454.32M |
| June 30, 2021 | 230.28M |
| March 31, 2021 | 224.26M |
| December 31, 2020 | 220.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 13.97B |
| Bio-Rad Laboratories, Inc. | 10.25B |
| Bruker Corp. | 6.053B |
| Danaher Corp. | 92.37B |
| Harvard Bioscience, Inc. | 76.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 124.98M |
| Shareholders Equity (Quarterly) | 321.95M |
| Debt to Equity Ratio | 0.1093 |
| Current Ratio | 4.481 |
| Net Debt Paydown Yield | -0.30% |